Frequently Asked Questions about Bausch Health Companies Inc. (BHC)

Name: Bausch Health Companies Inc. (BHC) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Bausch Health Companies Inc. (BHC) do?

Accepted Answer

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segm...

Question 2

Is Bausch Health Companies Inc. (BHC) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of BHC reveals an Altman Z-Score of 0.23 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($10.31B most recent), help investors decide if BHC fits their risk profile.

Question 3

What is the current P/E ratio for BHC?

Accepted Answer

As of the latest trading session, Bausch Health Companies Inc. (BHC) has a trailing P/E ratio of 12.55.

Question 4

Who is the CEO of Bausch Health Companies Inc.?

Accepted Answer

The current Chief Executive Officer of Bausch Health Companies Inc. is Thomas J. Appio.

Question 5

What was BHC's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Bausch Health Companies Inc. reported annual revenues of $10.31B (2025), $9.63B (2024), $8.76B (2023), $8.12B (2022), $8.43B (2021) respectively.

Question 6

Does BHC pay a dividend?

Accepted Answer

Bausch Health Companies Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does BHC have?

Accepted Answer

In its latest reporting period, Bausch Health Companies Inc. generated $1.00B in Free Cash Flow against a total debt load of $21.21B.

Question 8

What is the Price-to-Book (P/B) ratio of Bausch Health Companies Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Bausch Health Companies Inc. (BHC) is currently -3.52.

Question 9

What is the Price-to-Sales (P/S) ratio of BHC?

Accepted Answer

Based on trailing twelve-month data, Bausch Health Companies Inc. (BHC) trades at a Price-to-Sales (P/S) ratio of 0.19.

Question 10

What is Bausch Health Companies Inc.'s Return on Equity (ROE)?

Accepted Answer

Bausch Health Companies Inc. (BHC) has a Return on Equity (ROE) of -20.27%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	1.4B	216M	-397M	1B	787M
2024-12	1.6B	150M	-337M	1.3B	1.1B
2023-12	1B	132M	-272M	760M	628M
2022-12	-728M	126M	-268M	-996M	-1.1B
2021-12	1.4B	128M	-283M	1.1B	1B

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	1.4B	216M	-397M	1B	787M
2024-12	1.6B	150M	-337M	1.3B	1.1B
2023-12	1B	132M	-272M	760M	628M
2022-12	-728M	126M	-268M	-996M	-1.1B
2021-12	1.4B	128M	-283M	1.1B	1B